NCT04655261 - Study of Oral Venetoclax Tablets in Combination With Intravenous Obinutuzumab Injection to Assess Achievement of Best Response in Adult Participants With Chronic Lymphocytic Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 12, 2020

Primary Completion Date

November 9, 2021

Study Completion Date

November 9, 2021

Conditions

Chronic Lymphocytic Leukemia (CLL)

Trial Locations (4)

Moscow State budget healthcare /ID# 226058, Moscow

Russian Research Institute of Hematology and Transfusiology of the FMBA /ID# 231127, Saint Petersburg

Tula Regional Clinical Hospital /ID# 231128, Tula

Regional Children's Clinical Hospital of Volgograd /ID# 238328, Volgograd